Olivo, L.B.; de Lemos, J.L.S.; Rodrigues, V.J.; Kretschmer, D.B.; Cruz, W.d.A.; Staudt, K.J.; Annaert, P.; de Araújo, B.V.
PBPK/PD Model of Vancomycin in Sepsis: Linking Interstitial Exposure in Perfusion-Limited Tissues to MRSA Infection. Pharmaceutics 2025, 17, 1111.
https://doi.org/10.3390/pharmaceutics17091111
AMA Style
Olivo LB, de Lemos JLS, Rodrigues VJ, Kretschmer DB, Cruz WdA, Staudt KJ, Annaert P, de Araújo BV.
PBPK/PD Model of Vancomycin in Sepsis: Linking Interstitial Exposure in Perfusion-Limited Tissues to MRSA Infection. Pharmaceutics. 2025; 17(9):1111.
https://doi.org/10.3390/pharmaceutics17091111
Chicago/Turabian Style
Olivo, Laura Ben, Jéssica LuÃsa Silva de Lemos, Vinicius Jardim Rodrigues, Dúnia Batirola Kretschmer, William de Avila Cruz, Keli Jaqueline Staudt, Pieter Annaert, and Bibiana Verlindo de Araújo.
2025. "PBPK/PD Model of Vancomycin in Sepsis: Linking Interstitial Exposure in Perfusion-Limited Tissues to MRSA Infection" Pharmaceutics 17, no. 9: 1111.
https://doi.org/10.3390/pharmaceutics17091111
APA Style
Olivo, L. B., de Lemos, J. L. S., Rodrigues, V. J., Kretschmer, D. B., Cruz, W. d. A., Staudt, K. J., Annaert, P., & de Araújo, B. V.
(2025). PBPK/PD Model of Vancomycin in Sepsis: Linking Interstitial Exposure in Perfusion-Limited Tissues to MRSA Infection. Pharmaceutics, 17(9), 1111.
https://doi.org/10.3390/pharmaceutics17091111